10 瓶組庫存 3省 17%Retatrutide 40 mg
GLP-1 / GIP / 升糖素三促效劑研究用胜肽
Retatrutide tri-agonist research peptide, Australian-shipped. Lab-verified ≥99% purity.
僅供研究使用。 本化合物嚴格用於體外研究及實驗室用途，不得供人體食用或治療用途。購買即確認您為合格研究者，並同意我們的 完整免責聲明。
只剩 3 組
三受體促效劑研究用胜肽，文獻關注其在代謝研究中對 GLP-1、GIP 與升糖素訊號路徑的聯合作用。
Retatrutide is a synthetic tri-agonist research peptide that activates the GLP-1, GIP, and glucagon receptors simultaneously. It is part of a new generation of incretin-receptor research compounds developed to study combined activation of multiple metabolic pathways. Quantum Labs supplies Retatrutide as a lyophilised powder for Australian research applications.
Retatrutide is studied alongside other incretin-receptor agonists — semaglutide (single-agonist GLP-1) and tirzepatide (dual-agonist GLP-1/GIP) — in pre-clinical and clinical research literature. The tri-agonist mechanism is the distinguishing feature that places it in its own research category. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
作用機制
文獻關注其同時促效 GLP-1、GIP 與升糖素受體。研究與研究族群的代謝率、飽足感及能量消耗指標相關。
經 HPLC 驗證，純度規格 ≥99%。由獲認可的第三方實驗室獨立檢測。
Retatrutide — 常见問題
What is Retatrutide?
Retatrutide is a synthetic tri-agonist research peptide that simultaneously activates the GLP-1, GIP, and glucagon receptors. It is a newer-generation incretin-receptor research compound.
Is Retatrutide legal in Australia?
Retatrutide is not an approved therapeutic in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies Retatrutide for research use only — it is not a substitute for prescription weight-loss medication.
What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is a dual-agonist activating GLP-1 and GIP receptors. Retatrutide is a tri-agonist activating GLP-1, GIP, and glucagon receptors. The added glucagon-receptor activity is the distinguishing pharmacological feature of Retatrutide.
What is the difference between Retatrutide and Mounjaro?
Mounjaro is the brand name for the approved prescription medicine tirzepatide. Retatrutide is a separate research peptide with an additional glucagon-receptor agonism. They are different molecules studied in parallel research literature. Quantum Labs does not supply prescription medicines.
What is the typical Retatrutide research dosage?
Published clinical research has used Retatrutide doses across a wide titration range. Research-protocol dosing varies by model. Human therapeutic dosing is not established. Quantum Labs supplies this compound for laboratory and pre-clinical research use only. It is not represented for human therapeutic use, and questions about clinical dosing, treatment effects, or personal use should be directed to a qualified medical practitioner.
與 Retatrutide 相關的指南
研究者還會瀏覽
10 瓶組省 17%5-Amino-1MQ
凍乾粉末50 mg · 3 strengths
NNMT 抑制劑研究化合物
10 瓶組省 15%L-Carnitine
Sterile solution10 ml × 600 mg/ml
粒線體脂肪酸轉運分子
收錄於 1 套組合